INTRODUCTION
============

People suffering from cancer are more at risk to have secondary cancer, and this secondary cancer could be prevented by doing exercise. Therefore, researchers in the field of cancer focus on working out even after treating the disease. Studies performed with cancer patients show that exercise training has following benefits; improvement in shoulders' range of motion, muscle strength, balance, aerobic capacity, body image, weight control, sense of control, and quality of life, and decrease in therapeutic side effects (such as pain, fatigue, etc.) and depression ([@b9-jer-15-4-622]). Although being physically active is considered healthy independently from the type of exercise, some study findings indicate that combined exercise training is more effective in cancer patients than having only endurance or strength exercises ([@b1-jer-15-4-622]).

The second most prevalent type of cancer, and the second common cause of cancer-related death in Europe is colorectal cancer ([@b7-jer-15-4-622]). Even though colorectal cancer survivors generally suffer from cancer surgery and chemotherapy process as in other kinds of cancer, the number of survivors increase due to enhanced health care and early detection of disease ([@b14-jer-15-4-622]). The indirect effect of exercise on colorectal cancer is intensifying the bowel movements which reduce the duration of exposure carcinogenesis food with the intestine wall, and thereby reducing the risk of cancer ([@b19-jer-15-4-622]). Furthermore, hyperinsulinemia, in fact, insulin and complex of insulin growth factor family (IGF) trigger tumor growth, and they might be antiapoptosis. Exercise training inhibits the increase of insulin level and IGF families. Another relationship between exercise and colorectal cancer may be related to the combined effect of immunosuppressive, anti-inflammatory and antiapoptosis (in the condition of physiological disorder) consequences of exercise that have been proven in the previous studies ([@b8-jer-15-4-622]; [@b16-jer-15-4-622]). Scientists believe that an exercise training program, which is simultaneously accompanied by drug use, helps to improve patient's ability ([@b15-jer-15-4-622]). However, the real mechanism of the relationship between exercise and colorectal cancer is not yet known ([@b18-jer-15-4-622]).

Evidence suggests that there are at least four pathways for converting normal cells into colorectal cancer cells. The pathogenic pathway was first described by [@b11-jer-15-4-622]. This process is now known as the major mechanism for the most commonly occurring Adenomatous polyposis coli (APCs) events that result in colorectal cancer ([@b10-jer-15-4-622]). The second pathway for the development of colorectal cancer is the inherited or acquired mutation of the MMR gene or the specific hypermethylation of HMLMJ gene ([@b23-jer-15-4-622]). Ulcerative colitis is the third pathway for colorectal cancer ([@b3-jer-15-4-622]), and has a weaker role in the development of cancer compared to other pathways. On the fourth pathway, colorectal cancer occurs from cells in which the estrogen receptor (ER) cells are muted. The muted MLH1 and P16 and hypermethylation of ER are a phenomenon associated with age ([@b19-jer-15-4-622]). An APC or, in other words, mutated beta-catenin leads to adrenal insufficiency and proper cell migration, and translates the signaling pathway for propagation ([@b12-jer-15-4-622]). On the other hand, beta-catenin mutations can additionally lead to the removal of APC ([@b20-jer-15-4-622]). The final result will be the creation of carcinoma in the intestines. In this regard, the activation of the beta-catenin-Wnt route is important. The Wnt family of ligands can interact with different receivers and activate various downstream paths. This pathway is classified into two subcategories called the beta-catenin pathway and the non-beta-catenin pathway.

The roots of apoptosis caused by the use of certain drugs in patients with colorectal cancer lie in the changes of SSTR2 and SSTR5. In fact, the somatostatin hormone peptide and its receptors (SSTRs) have a wide range of physiological functions. They additionally play a role in treating severe conditions such as colorectal cancer. The effect of exercise training on the resolution of the disorder probably caused by the process of apoptosis in patients with colorectal cancer is likely to be similar to certain drugs. The question of the current study is "How does a combined exercise program affect hormonal and physiological changes, especially in the SSTR2 and SSTR5 in patients with colorectal cancer?"

MATERIALS AND METHODS
=====================

Research methodology
--------------------

Regarding the aforementioned signaling pathways, which are also stimulated by sports activities, it seems that performing regular exercise activities can have an auxiliary and facilitating role by influencing the aforementioned pathways and increasing SSTR2 and SSTR5. With this viewpoint, researchers studied the effect of combined exercise (various other types of exercises that were more effective in cancer patients) on SSTRs changes. The participants were selected from patients with colorectal cancer who were diagnosed and were undergoing treatment (radiotherapy and chemotherapy) at the department of oncology of Vali-e-Asr Hospital in Zanjan. Samples were selected by the consent of the participants and they were divided into two groups as experimental (n=10; mean age, 55.2±15.3 years; mean body weight, 75.20±4.45 kg) and control group (n=10; mean age, 57.3±14.5 years; mean body weight, 67.34±6.52 kg). Each group included four women and six men.

Exercise training protocol
--------------------------

The exercise program was designed according to the recommendations of ACSM ([@b1-jer-15-4-622]). While the experimental group performed the training program 5 days a week for 14 weeks, the control group did not take part in any exercise program during the 14 weeks. Blood samples were taken from the patient's arms at 9 mL before the program started, and it was repeated at the posttest by the blood sampling specialist of the laboratory. After the initial testing, their exercise training program was performed as follows (3 days a week of endurance training and 2 days of resistance training) as follows: Three days a week (every other day) endurance exercise was performed in the form of running (walking) on a treadmill. In the first few weeks, when the heart rate ran higher than the intended rate (between 110 and 130 beats/min), the exercise was immediately stopped, and after a little of rest, the patient started to exercise again. The program was stopped even 3 times for some patients. After the third week, it gradually became more consistent and program stoppage declined, with no stops in the final 2 weeks (weeks 13 and 14). Despite the 55 min of exercise on the treadmill, the heart rate of the experimental group members did not go higher than 130 beats/min. Strength training included the following movements: bench presses, cable rows, moving the feet in and out (thigh abductor), fixed bar stretch, leg presses and leg curls which started with 40% one-repetition maximum (1RM) and in one set with eight repetitions in the first two weeks. These moves progressed gradually to 60% 1RM, in three sets with ten repetitions in the final weeks. The moves were calculated based on the force variation (weight).

Laboratory method
-----------------

Somatostatin and its receptors were tested according to the instructions on the brochure kit which was provided from the Bioassay Technology Laboratory Company in China.

Statistical analysis
--------------------

IBM SPSS Statistics ver. 20.0 (IBM Co., Armonk, NY, USA) was used for statistical data analyzes in the research. Firstly, the distribution of data was tested for parametric or nonparametric tests. Normality distribution was tested by Shapiro--Wilk, and for normal distribution parametric Paired sample *t*-test, and for nonparametric distribution Wilcoxon tests were used. Analysis of covariance was used to compare the groups with pre- and posttest. Alpha value was accepted as 0.05 for all of the statistical analyzes.

RESULTS
=======

[Tables 1](#t1-jer-15-4-622){ref-type="table"} and [2](#t2-jer-15-4-622){ref-type="table"} present the results of the effect of the combined training programs on SSTR2 changes in patients with colorectal cancer.

The effect of the independent variable is 0.387 (*F*) and its significance value is 0.543 which is more than the recommended level (*P*\<0.05). That is, if the pretest effect is excluded, there will not be any significant difference in SSTR2 variable between the two groups in posttest. Therefore, the research hypothesis that SSTR2 improves after combined training programs is rejected ([Table 1](#t1-jer-15-4-622){ref-type="table"}). The predicted value of covariance for SSTR2 variable (total covariance) in the evaluated model was 52.75 ([Table 2](#t2-jer-15-4-622){ref-type="table"}). Results of the mean of SSTR2 in the experimental group and control group in pre- and posttest are also presented in [Fig. 1](#f1-jer-15-4-622){ref-type="fig"}.

[Table 3](#t3-jer-15-4-622){ref-type="table"} presents the results of the effect of the combined training program on SSTR5 changes in patients with colorectal cancer. The effect of the independent variable is 0.354 (*F*) and its significance value is 0.56 which is more than the recommended level (*P*\<0.05). That is, if the pretest effect is excluded, there will not be any significant difference in SSTR5 between the two groups in posttest. Hence, the research hypothesis that SSTR5 improves after combined training programs is rejected ([Table 3](#t3-jer-15-4-622){ref-type="table"}).

Predicted value of covariance for SSTR5 variable (total covariance) in the evaluated model was 27.52 ([Table 4](#t4-jer-15-4-622){ref-type="table"}). Results of the mean of SSTR5 in experimental group and control group in pre- and posttest are also presented in [Fig. 2](#f2-jer-15-4-622){ref-type="fig"}.

DISCUSSION
==========

Colorectal surgery decreases physiological and functional capacities about 20% to 40% ([@b13-jer-15-4-622]), and these postoperative decreases could be observed 6 to 8 weeks long after the leaving of hospital ([@b5-jer-15-4-622]). Even though colorectal cancer patients who had chemotherapy and radiotherapy show prolonged functional and physical inability ([@b17-jer-15-4-622]), they could reduce the mortality risk about 39% with a physically active life after the diagnosis ([@b25-jer-15-4-622]). The current study aimed to investigate the effects of combined strength and cardiorespiratory endurance training in colorectal cancer patients. Similar study investigating the effects of combined aerobic and resistance training on some physical fitness parameters was performed [@b26-jer-15-4-622], and they reported significant effects of combined resistance and aerobic training program on strength, body composition, flexibility and cardiorespiratory fitness parameters. [@b14-jer-15-4-622] observed improved physical activity level, and more importantly physical fitness level after 6 weeks of home-based combined aerobic and resistance exercise program in colorectal cancer patients. According to [@b17-jer-15-4-622] performing a walking and breathing based prerehabilitation program before the surgery is also effective on physical and functional parameters in patients with colorectal cancer. Effects of 8-week of aerobic training were investigated on plasma leptin and ghrelin concentrations in male patients with colorectal cancer, and it was seen that aerobic exercise training improves the body composition, maximum oxygen uptake (VO~2max~) and ghrelin concentration significantly while there was no significant enhancement on plasma leptin concentration ([@b21-jer-15-4-622]). [@b6-jer-15-4-622] reported that high-intensity interval exercise is more effective on body composition and VO~2max~ values than moderate intensity continuous exercise training in colorectal cancer patients in 12 weeks.

As it was mentioned earlier, the roots of apoptosis caused by using some medicine among patients with colorectal cancer lie in the changes in SSTR2 and SSTR5. Lanreotide and octreotide are the medicines used by patients suffering from colorectal cancer and their role is similar to the inhibitory role of somatostatin ([@b9-jer-15-4-622]). One way that colon cells are infected by cancer is the disorders in the apoptosis process ([@b8-jer-15-4-622]). [@b30-jer-15-4-622] showed that octreotide which is used at some stages of treating these patients increases phosphorylation of beta-catenin followed by the improvement of apoptosis when the level of SSTR2 and SSTR5 is increased ([@b30-jer-15-4-622]). One of the antiproliferation mechanisms of somatostatin and its receptors (SSTRs) is inhibiting cell growth factors from messaging ([@b28-jer-15-4-622]), including the colon cancer cells. With their high tendency of being combined with somatostatin, SSTR2 and SSTR5 receptors protect tumors, inhibit adenylate cyclase and as a result of producing cAMP, they reduce the activities of protein kinase, stimulate phospholipase C (PLC) and move Ca^2+^ and activate MAPK ([@b2-jer-15-4-622]; [@b4-jer-15-4-622]; [@b22-jer-15-4-622]; [@b29-jer-15-4-622]).

Some medications used in colorectal cancer such as octreotide inhibit the growth of 480SW cells (colorectal cancer cells). [@b30-jer-15-4-622] showed that this drug negatively sets beta-catenin- Wnt pathway by SSTRs. SSTRs also cause apoptosis by inducing acidosis ([@b27-jer-15-4-622]). SSTR2 is the most important anti-propagating mediator of somatostatin and it is considered a primary receptor in studies on the beneficial effects of somatostatin receptors and the receptor itself is a tumor protective in pancreatic cancer since it disappears at the time of infection ([@b2-jer-15-4-622]). SSTR5 is known as the high-affinity receptor with somatostatin-28 ([@b22-jer-15-4-622]). According to the research findings showed a significant increase in the values of SSTR2 and SSTR5 ([Tables 1](#t1-jer-15-4-622){ref-type="table"} and [3](#t3-jer-15-4-622){ref-type="table"}, respectively). The increase in SSTR2 and SSTR5 in the control group, which only undergone treatment, was more than the experimental group ([Figs. 1](#f1-jer-15-4-622){ref-type="fig"} and [2](#f2-jer-15-4-622){ref-type="fig"}, respectively). But researchers have already shown the effectiveness of endurance and strength training to improve the physical function of these patients ([@b24-jer-15-4-622]). Improving the abilities of patients with colorectal cancer probably increases the ability to withstand the disease by increasing life expectancy. Since it seems to be the first study in this field, the results of the present study cannot be mentioned to be consistent or inconsistent with other findings and properly elaborate on the cause of changes. It is noteworthy that the normal range of SSTR2 is 0.5--150 ng/mL and the value of SSTR2 in one of the patients of the experimental group (young man) was 237.17 ng/mL in the pretest stage, which reduced after 14 weeks of training to 160.16 ng/mL in the posttest. In addition, the normal range of SSTR5 is 0.2--60 ng/mL and this value was 114.1 ng/mL in this patient during the pretest, which reduced to 96.8 ng/mL in the posttest. Although the aforementioned medicine is used to increase the value of SSTRs, considering the normal range of these receptors, combined exercise training can probably play a role in normalizing the level of receptors in cases where they are higher than the normal range. In this regard, exercise training program can be considered a positive intervention. Nonetheless, this hypothesis calls for a wide range of studies.

According to the results of some studies, it can be probably stated that performing combined exercise training by patients with colorectal cancer, specially the survivors whose treatment have been a success, improves their body factors and increases their performance which leads to an increase in their resistance against the consequences of the disease. However, ineffectiveness of this exercise training program on the values of SSTRs shows that more studies are required in this field so that the required results can be achieved by making changes in the trend of training programs. Finally, it seems that the training program of these patients needs to be of the combined type and performed for at least 3 months in a gradual incremental structure so that it can affect their health significantly.
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###### 

Dependent variable: SSTR2 posttest

  Variable               Type III sum of squares   Degree of free   Mean square   *F*      Sig
  ---------------------- ------------------------- ---------------- ------------- -------- --------
  Modified model         9,625,988.96              2                12,994.48     99.05    0.0001
  Stymie rate            6,233.43                  1                6,233.43      47.51    0.0001
  SSTR2 pretest          22,969.80                 1                22,969.80     175.08   0.0001
  Group                  50.74                     1                50.74         0.387    0.543
  Error                  1,967.87                  15               131.9         \-       \-
  Total score            82,354.05                 18               \-            \-       \-
  Modified total score   27,956.84                 17               \-            \-       \-

###### 

Total covariance in the evaluation model of SSTR2 variable (ng/mL)

  Group                Mean±SD      95% CI
  -------------------- ------------ --------------
  Experimental group   53.15±3.97   44.67--61.63
  Control group        56.79±3.97   48.31--65.26

SD, standard deviation; CI, confidence interval.

Predicted value of covariance for SSTR2 variable: 52.75.

###### 

Dependent variable: SSTR5 posttest

  Variable               Type III sum of squares   Degree of free   Mean square   *F*      Sig
  ---------------------- ------------------------- ---------------- ------------- -------- --------
  Modified model         8,006.055                 2                4,003.027     76.96    0.0001
  Stymie rate            2,930.3                   1                2,930.33      56.34    0.0001
  SSTR5 pretest          7,144.93                  1                7,144.93      137.38   0.0001
  Group                  18.43                     1                18.436        0.354    0.56
  Error                  780.12                    15               52.008        \-       \-
  Total score            32,730.19                 18               \-            \-       \-
  Modified total score   8,786.17                  17               \-            \-       \-

###### 

Total covariance in the evaluation model of SSTR5 variable (ng/mL)

  Group                Mean±SD      95% CI
  -------------------- ------------ --------------
  Experimental group   35.38±2.49   30.05--40.70
  Control group        37.56±2.49   32.23--42.89

SD, standard deviation; CI, confidence interval.

Predicted value of covariance for SSTR5 variable: 27.52.
